T1	Condition 0 18	Richter's syndrome
T2	Condition 20 38	Burkitt's lymphoma
T3	Condition 43 64	Burkitt-like Lymphoma
T4	Condition 78 83	DLBCL
T5	Condition 89 103	Follicular NHL
*	OR T5 T4 T3 T2 T1
T6	Procedure 126 136	transplant
T7	Procedure 142 160	stem cell infusion
T8	Temporal 161 168;222 230	90 days of Day 1
T9	Temporal 172 178	active
T10	Procedure 179 206	graft-versus-host treatment
T11	Temporal 207 230	within 8 weeks of Day 1
R1	Has_temporal Arg1:T10 Arg2:T11	
T12	Drug 252 266	SYK inhibitors
T13	Procedure 239 246	therapy
R2	AND Arg1:T13 Arg2:T12	
T14	Temporal 233 238	Prior
T15	Temporal 120 125	Prior
R3	Has_temporal Arg1:T6 Arg2:T15	
R4	Has_temporal Arg1:T13 Arg2:T14	
R5	AND Arg1:T6 Arg2:T7	
R6	Has_temporal Arg1:T6 Arg2:T8	
R7	Has_temporal Arg1:T10 Arg2:T9	
*	OR T10 T6
T16	Drug 292 315	strong CYP3A4 inhibitor
T17	Drug 292 305;317 324	strong CYP3A4 inducer
T18	Drug 326 345	acid reducing agent
T19	Drug 347 369	Proton pump inhibitors
*	OR T19 T18 T17 T16
T20	Condition 377 412	lymphomatous involvement of the CNS
T21	Undefined_semantics 377 412	lymphomatous involvement of the CNS
T22	Measurement 438 452	NCI CTCAE v4.0
T23	Value 453 462	≥ Grade 2
R8	Has_value Arg1:T22 Arg2:T23	
T24	Condition 473 494	drug-related toxicity
T25	Temporal 464 472	previous
T26	Condition 503 511	alopecia
T27	Negation 496 502	except
T28	Condition 513 531	erectile impotence
T29	Condition 533 544	hot flashes
T30	Condition 546 552	libido
T31	Condition 554 564	neuropathy
*	OR T31 T30 T29 T28 T26
T32	Scope 503 564	alopecia, erectile impotence, hot flashes, libido, neuropathy
R9	Has_negation Arg1:T32 Arg2:T27	
R10	Has_temporal Arg1:T24 Arg2:T25	
T33	Drug 574 593	monoclonal antibody
T34	Drug 595 615	radioimmunoconjugate
T35	Drug 617 640	antibody drug conjugate
T36	Procedure 642 654	phototherapy
T37	Procedure 656 668	radiotherapy
T38	Procedure 670 682	chemotherapy
T39	Procedure 684 697	immunotherapy
T40	Procedure 699 724	immunosuppressive therapy
T41	Temporal 744 758;786 794	within 3 weeks of Day 1
T42	Drug 766 777	alemtuzumab
A1	Optional T42
T43	Temporal 778 794	8 weeks of Day 1
T44	Scope 574 724	monoclonal antibody, radioimmunoconjugate, antibody drug conjugate, phototherapy, radiotherapy, chemotherapy, immunotherapy, immunosuppressive therapy
T45	Scope 744 794	within 3 weeks or for alemtuzumab 8 weeks of Day 1
*	OR T41 T42
T46	Reference_point 789 794	Day 1
R11	Has_index Arg1:T41 Arg2:T46	
R12	Has_index Arg1:T43 Arg2:T46	
R13	Has_scope Arg1:T44 Arg2:T45	
T47	Condition 801 805	CTCL
T48	Procedure 808 813	TSEBT
T49	Temporal 815 830	within 12 weeks
R14	Has_temporal Arg1:T48 Arg2:T49	
T50	Drug 849 864	topical steroid
T51	Observation 835 845	initiation
R15	Has_context Arg1:T50 Arg2:T51	
T52	Drug 866 882	nitrogen mustard
T53	Drug 887 903	topical retinoid
T54	Temporal 904 918	within 2 weeks
*	OR T50 T52 T53
T55	Scope 849 903	topical steroid, nitrogen mustard, or topical retinoid
R16	Has_temporal Arg1:T55 Arg2:T54	
T56	Temporal 936 960	≥ 4 weeks prior to Day 1
T57	Reference_point 955 960	Day 1
R17	Has_index Arg1:T56 Arg2:T57	
T58	Grammar_Error 961 968	allowed
T59	Condition 989 1006	infection for HIV
T60	Condition 1007 1012;989 1002	Hep B infection for
T61	Condition 1007 1010;1016 1017;989 1002	Hep C infection for
*	OR T61 T60 T59
T62	Condition 1019 1026	HCV ab+
T63	Qualifier 1035 1039	PCR-
R18	Has_qualifier Arg1:T62 Arg2:T63	
T64	Condition 1041 1048	HBV ab+
T65	Qualifier 1057 1063	HBsAg-
R19	Has_qualifier Arg1:T64 Arg2:T65	
T66	Condition 1067 1083	undetectable DNA
A2	Optional T62
A3	Optional T64
T67	Scope 989 1017	infection for HIV/Hep B or C
*	OR T67 T62 T64
T68	Condition 1092 1101	infection
T69	Procedure 1112 1130	systemic treatment
T70	Qualifier 1102 1130	requiring systemic treatment
R20	AND Arg1:T70 Arg2:T69	
R21	Has_qualifier Arg1:T68 Arg2:T70	
T71	Condition 1145 1155	GI disease
T72	Qualifier 1133 1144	Significant
T73	Subjective_judgement 1133 1144	Significant
R22	Has_qualifier Arg1:T71 Arg2:T72	
T74	Procedure 1180 1193	bowel surgery
T75	Procedure 1172 1179;1186 1193	gastric surgery
T76	Qualifier 1166 1171	major
T77	Subjective_judgement 1166 1171	major
*	OR T75 T74
T78	Condition 1195 1216	difficulty swallowing
T79	Condition 1220 1242	malabsorption syndrome
*	OR T79 T78
T80	Scope 1172 1193	gastric/bowel surgery
R23	Has_qualifier Arg1:T80 Arg2:T76	
R24	AND Arg1:T80 Arg2:T78	
T81	Procedure 1251 1258	surgery
T82	Qualifier 1245 1250	Major
T83	Undefined_semantics 1245 1250	Major
T84	Subjective_judgement 1245 1250	Major
R25	Has_qualifier Arg1:T81 Arg2:T82	
T85	Temporal 1259 1273	within 4 weeks
R26	Has_temporal Arg1:T81 Arg2:T85	
T86	Condition 1284 1296	malignancies
T87	Temporal 1297 1310	within 2 yrs.
T88	Non-query-able 1311 1346	unless relapse risk is small (< 5%)
T89	Subjective_judgement 1311 1346	unless relapse risk is small (< 5%)
T90	Undefined_semantics 1311 1346	unless relapse risk is small (< 5%)
R27	Has_temporal Arg1:T86 Arg2:T87	
T91	Drug 1364 1381	systemic steroids
T92	Multiplier 1382 1391	>20 mg QD
T93	Drug 1392 1402	prednisone
R28	Subsumes Arg1:T91 Arg2:T93	
R29	Has_multiplier Arg1:T93 Arg2:T92	
T94	Observation 1420 1433	Breastfeeding
T95	Condition 1437 1445	pregnant
T96	Person 1468 1475	females
*	OR T95 T94
